Paragon Biosciences: Funding, Investors & Team (Sep 2026)
A pioneer in life sciences, Paragon founds, finances, and develops bioscience businesses. We overcome difficult problems by developing science. The four areas of life science innovation that Paragon focuses on include biopharmaceuticals, gene therapy, synthetic biology, and artificial intelligence. Castle Creek Biosciences, Emalex Biosciences, Evozyne, Harmony Biosciences, Qlarity Imaging, Skyline Biosciences, and a steady stream of developing incubating startups make up our current portfolio. At the nexus of human need, life science, and business creation is Paragon.
Paragon Biosciences has raised $185M across 1 funding round on record, the most recent an undisclosed round of $185M announced in Nov 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Paragon Biosciences Company Profile and Key Stats
Latest funding round on record: Nov 2022.
Paragon Biosciences Funding Rounds
Paragon Biosciences Founders and Leadership Team
No contact details are on record for this team yet.
Paragon Biosciences Funding Compared to Other Biotechnology Startups
Paragon Biosciences' latest round of $185M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Paragon Biosciences in Biotechnology and Chicago
Companies Similar to Paragon Biosciences
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paragon Biosciences Funding FAQs
What does Paragon Biosciences do?
A pioneer in life sciences, Paragon founds, finances, and develops bioscience businesses. We overcome difficult problems by developing science. The four areas of life science innovation that Paragon focuses on include biopharmaceuticals, gene therapy, synthetic biology, and artificial intelligence. Castle Creek Biosciences, Emalex Biosciences, Evozyne, Harmony Biosciences, Qlarity Imaging, Skyline Biosciences, and a steady stream of developing incubating startups make up our current portfolio. At the nexus of human need, life science, and business creation is Paragon.
How much funding has Paragon Biosciences raised?
Paragon Biosciences has raised $185M across 1 round on record. The most recent is an undisclosed round of $185M announced in Nov 2022.
When did Paragon Biosciences last raise funding?
Paragon Biosciences' most recent funding round on record is an undisclosed round of $185M, announced in Nov 2022.
Who is the CEO of Paragon Biosciences?
Jeffrey Aronin is listed as CEO at Paragon Biosciences.
Where is Paragon Biosciences headquartered?
Paragon Biosciences is based in Chicago, Illinois, United States.
How many employees does Paragon Biosciences have?
Paragon Biosciences is in the 11-50 employee band.
How does Paragon Biosciences' funding compare to other Biotechnology startups?
Paragon Biosciences' latest round of $185M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Paragon Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Paragon Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.